The combination of a 41% PT cut from a mid-accuracy firm, 9 downgrades in 30 days, and heavy insider selling creates a distinctly bearish setup ahead of earnings on November 17. However, the institutional buying wave and upward EPS revisions for longer-term periods suggest the market is pricing in a near-term trough, making the earnings print a critical catalyst for direction.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 12 $166.19entry
- T+1 · 4d ago −2.01%α −1.65% · $162.85
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Melius Research cut its price target on NVDA by 41% to $185 and downgraded the stock from Buy to Hold on November 12, 2026, citing a fundamental reassessment of near-term growth prospects. The firm's 54% accuracy on 69 calls and average 5% return place it near the middle of the analyst pack, but the magnitude of the PT cut is the largest among 57 covering analysts. Consensus remains overwhelmingly bullish with 66 of 69 analysts at Buy or Strong Buy, a mean target of $319.99 implying 84% upside from the current $173.73. However, NVDA has seen 9 downgrades in the past 30 days versus 0 upgrades, and the stock is trading 46% below the consensus mean target. EPS revisions over the past 30 days show 7 upward revisions for the +1y period and 2 for the current fiscal year, with no downward revisions, suggesting analysts are still raising long-term estimates even as near-term sentiment sours. Insider selling has been heavy, with EVP Teter Timothy S. selling $6.8M under a 10b5-1 plan and director Mark Stevens selling $300M in open-market trades, creating a bearish cross-signal. With earnings due November 17, this downgrade adds to a growing chorus of caution ahead of the print.
Impact Score
Consensus & Targets
Of 69 analysts covering NVDA, 66 (96%) rate it Buy or Strong Buy, 2 (3%) rate it Hold, and 1 (1%) rates it Sell. The consensus is overwhelmingly bullish, making Melius's downgrade to Hold a contrarian call against the prevailing view.
The mean price target is $319.99, median $315, high $515, low $180. NVDA currently trades at $173.73, implying 84% upside to the mean. Melius's $185 PT sits just above the consensus low of $180, making it one of the most bearish targets on the street.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-12 | Melius Research | downgrade | Hold | $185.00 |
| 2026-11-12 | DA Davidson | maintain | Buy | No target |
| 2026-11-12 | Craig-Hallum | downgrade | Hold | $180.00 |
| 2026-11-12 | B of A Securities | maintain | Buy | $280.00 |
| 2026-11-12 | BMO Capital | maintain | Outperform | No target |
| 2026-11-12 | Baird | reiterate | Neutral | No target |
| 2026-11-12 | Goldman Sachs | maintain | Buy | No target |
| 2026-11-12 | Citigroup | maintain | Buy | No target |
| 2026-11-12 | Needham | maintain | Buy | $200.00 |
| 2026-11-12 | StoneX | downgrade | Hold | No target |
In the past 30 days, NVDA has received 0 upgrades and 9 downgrades, including Melius, Craig-Hallum (to Hold, PT $180), and StoneX (to Hold). EPS revisions show 7 upward revisions for the +1y period and 2 for the current fiscal year, with 0 downward revisions, indicating analysts are still raising long-term estimates despite near-term downgrades.
Firm Track Record: Melius Research
Melius Research accuracy: 54% on 69 calls | avg return: 5%
Industry benchmark: mean 45% ± 8%. Top tier: ≥53% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| New Street Research | 100% | 2/2 | 19.5% | top tier |
| Raymond James | 86% | 6/7 | 26.4% | top tier |
| Piper Sandler | 71% | 5/7 | 20.3% | top tier |
| Rosenblatt | 65% | 15/23 | 12.3% | top tier |
| Tigress Financial | 60% | 3/5 | -1.8% | top tier |
| Loop Capital | 60% | 3/5 | 4.6% | top tier |
| RBC Capital | 60% | 3/5 | 5.7% | top tier |
| Barclays | 60% | 6/10 | 13.7% | top tier |
| Benchmark | 60% | 9/15 | 9% | top tier |
| Needham | 57% | 8/14 | 11.1% | top tier |
Melius Research has a 54% accuracy rate on 69 scored calls with an average return of 5%, placing it near the middle of the 15 firms tracked. Top-tier firms include New Street Research (100% on 2 calls, avg return 19.5%) and Raymond James (86% on 7 calls, avg return 26.4%). The weakest tracked firm is Tigress Financial (60% on 5 calls, avg return -1.8%).
Earnings Estimates
Next earnings: Nov 17, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $15.91 | $12.85 to $18.75 | $691.4B | ↑3 ↓0 |
| 0q | $2.47 | $2.34 to $2.70 | $109.0B | ↑0 ↓0 |
| +1q | $2.75 | $2.56 to $3.12 | $124.7B | ↑0 ↓0 |
| 0y | $9.32 | $9.01 to $10.10 | $411.9B | ↑2 ↓0 |
Cross-Platform Signals
Insider selling is heavy: EVP Teter Timothy S. sold $6.8M under a 10b5-1 plan on September 21, and director Mark Stevens sold $300M in open-market trades on September 18 (not under a plan). Congressional activity is mixed, two Republican buys (Rep. Salazar, Oct 23) and three sells (Democrats Cisneros and Khanna, Republican Sessions). Institutional changes show large adds from BNP Paribas ($10B), Cardano Risk Management ($2.3B), and a new position from Barrow Hanley ($508M), signaling institutional accumulation. Short-sale volume data is not available. The insider sales and analyst downgrades converge bearishly, while institutional buying diverges as a potential contrarian signal.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
62 reports on NVDA
5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +18.74% at T+60 after the Feb 25, 2026 report. 19 of 20 went positive at some point.
Filters
- Nov 16, 2026today 13F-HR Neutral 3/10 Entry $156.72 Now $162.85 +3.91% settles Feb 16
- Nov 16, 2026today Press Release Neutral 3/10 Entry $158.77 Now $162.85 +2.57% settles Feb 12
- Nov 13, 20263d ago ANALYST-DOWNGRADE Bearish 6/10 Entry $162.85 Now $162.85 −0.00% settles Feb 11
- Nov 12, 20264d ago ANALYST-DOWNGRADE Bearish 7/10 Viewing Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago 8-K Bearish 7/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago Press Release Bearish 7/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago ANALYST-DOWNGRADE Bearish 6/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 12, 20264d ago ANALYST-DOWNGRADE Bearish 7/10 Entry $166.19 Now $162.85 +2.01% settles Feb 10
- Nov 11, 20265d ago ANALYST-DOWNGRADE Bearish 4/10 Entry $173.73 Now $162.85 +6.26% settles Feb 9
- Nov 9, 20266d ago Institutional Cluster Neutral 3/10 Entry $168.89 Now $162.85 −3.58% settles Feb 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers